Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 2
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Aripov VS, Shanshin DV, Karpenko LI, Belenkaya SV, Kazachinskaia EI, Volosnikova EA, Esina TI, Sergeev AA, Titova KA, Konyakhina YV, Zaykovskaya AV, Pyankov OV, Kolosova EA, Viktorina OE, Shelemba AA, Rudometov AP, Ilyichev AA. Merkuleva IA, et al. Among authors: rudometov ap. Viruses. 2022 May 16;14(5):1060. doi: 10.3390/v14051060. Viruses. 2022. PMID: 35632800 Free PMC article.
Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate.
Karpenko LI, Rudometov AP, Sharabrin SV, Shcherbakov DN, Borgoyakova MB, Bazhan SI, Volosnikova EA, Rudometova NB, Orlova LA, Pyshnaya IA, Zaitsev BN, Volkova NV, Azaev MS, Zaykovskaya AV, Pyankov OV, Ilyichev AA. Karpenko LI, et al. Among authors: rudometov ap. Vaccines (Basel). 2021 Jan 21;9(2):76. doi: 10.3390/vaccines9020076. Vaccines (Basel). 2021. PMID: 33494530 Free PMC article.
Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens.
Starostina EV, Sharabrin SV, Antropov DN, Stepanov GA, Shevelev GY, Lemza AE, Rudometov AP, Borgoyakova MB, Rudometova NB, Marchenko VY, Danilchenko NV, Chikaev AN, Bazhan SI, Ilyichev AA, Karpenko LI. Starostina EV, et al. Among authors: rudometov ap. Vaccines (Basel). 2021 May 3;9(5):452. doi: 10.3390/vaccines9050452. Vaccines (Basel). 2021. PMID: 34063689 Free PMC article.
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems.
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Shanshin DV, Rudometov AP, Karpenko LI, Belenkaya SV, Isaeva AA, Nesmeyanova VS, Kazachinskaia EI, Volosnikova EA, Esina TI, Zaykovskaya AV, Pyankov OV, Borisevich SS, Shelemba AA, Chikaev AN, Ilyichev AA. Merkuleva IA, et al. Among authors: rudometov ap. Vaccines (Basel). 2022 Jan 9;10(1):96. doi: 10.3390/vaccines10010096. Vaccines (Basel). 2022. PMID: 35062757 Free PMC article.
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.
Borgoyakova MB, Karpenko LI, Rudometov AP, Volosnikova EA, Merkuleva IA, Starostina EV, Zadorozhny AM, Isaeva AA, Nesmeyanova VS, Shanshin DV, Baranov KO, Volkova NV, Zaitsev BN, Orlova LA, Zaykovskaya AV, Pyankov OV, Danilenko ED, Bazhan SI, Shcherbakov DN, Taranin AV, Ilyichev AA. Borgoyakova MB, et al. Among authors: rudometov ap. Int J Mol Sci. 2022 Feb 16;23(4):2188. doi: 10.3390/ijms23042188. Int J Mol Sci. 2022. PMID: 35216301 Free PMC article.
Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol.
Kisakov DN, Kisakova LA, Borgoyakova MB, Starostina EV, Taranov OS, Ivleva EK, Pyankov OV, Zaykovskaya AV, Shcherbakov DN, Rudometov AP, Rudometova NB, Volkova NV, Gureev VN, Ilyichev AA, Karpenko LI. Kisakov DN, et al. Pharmaceutics. 2022 Oct 22;14(11):2259. doi: 10.3390/pharmaceutics14112259. Pharmaceutics. 2022. PMID: 36365078 Free PMC article.
Immunogenic and Protective Properties of Recombinant Hemagglutinin of Influenza A (H5N8) Virus.
Rudometova NB, Fando AA, Kisakova LA, Kisakov DN, Borgoyakova MB, Litvinova VR, Yakovlev VA, Tigeeva EV, Vahitov DI, Sharabrin SV, Shcherbakov DN, Evseenko VI, Ivanova KI, Gudymo AS, Ilyicheva TN, Marchenko VY, Ilyichev AA, Rudometov AP, Karpenko LI. Rudometova NB, et al. Among authors: rudometov ap. Vaccines (Basel). 2024 Jan 29;12(2):143. doi: 10.3390/vaccines12020143. Vaccines (Basel). 2024. PMID: 38400127 Free PMC article.